Dyadic International Inc (DYAI) stock
DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.32−0.00 (-1.25%)
Close on Nov 17, 2026Market cap $11.51MP/E –Yield –
Dyadic International operating margin
Operating margin is operating income as a percentage of revenue.
Dyadic International's operating margin for the twelve months ending Sep 30, 2026 was -236.7%. For fiscal 2025 it was -232.8%, against -168.8% the year before. The highest annual figure on record is -168.8% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -232.8% | −63.9 |
| FY2024 | Dec 31, 2024 | -168.8% | +115.1 |
| FY2023 | Dec 31, 2023 | -283.9% | +63.0 |
| FY2022 | Dec 31, 2022 | -346.9% | +265.8 |
| FY2021 | Dec 31, 2021 | -612.7% | +13.2 |
| FY2020 | Dec 31, 2020 | -625.9% | −73.7 |
| FY2019 | Dec 31, 2019 | -552.2% | +33.9 |
| FY2018 | Dec 31, 2018 | -586.1% | +353.6 |
| FY2017 | Dec 31, 2017 | -939.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -403.6% | −238.2 |
| Q2 FY2026 | Jun 30, 2026 | -213.7% | −34.9 |
| Q1 FY2026 | Mar 31, 2026 | -171.3% | +337.5 |
| Q4 FY2025 | Dec 31, 2025 | -271.6% | −84.4 |
| Q3 FY2025 | Sep 30, 2025 | -165.3% | −155.0 |
| Q2 FY2025 | Jun 30, 2025 | -178.9% | +350.4 |
| Q1 FY2025 | Mar 31, 2025 | -508.8% | +126.4 |
| Q4 FY2024 | Dec 31, 2024 | -187.2% | +128.7 |
| Q3 FY2024 | Sep 30, 2024 | -10.4% | +422.9 |
| Q2 FY2024 | Jun 30, 2024 | -529.3% | −255.7 |
| Q1 FY2024 | Mar 31, 2024 | -635.2% | −425.6 |
| Q4 FY2023 | Dec 31, 2023 | -315.9% | −14.8 |
| Q3 FY2023 | Sep 30, 2023 | -433.2% | −221.4 |
| Q2 FY2023 | Jun 30, 2023 | -273.6% | +230.2 |
| Q1 FY2023 | Mar 31, 2023 | -209.7% | +213.6 |
| Q4 FY2022 | Dec 31, 2022 | -301.1% | +1044.5 |
| Q3 FY2022 | Sep 30, 2022 | -211.9% | +267.8 |
| Q2 FY2022 | Jun 30, 2022 | -503.8% | −91.2 |
| Q1 FY2022 | Mar 31, 2022 | -423.3% | +297.8 |
| Q4 FY2021 | Dec 31, 2021 | -1345.7% | −689.8 |
| Q3 FY2021 | Sep 30, 2021 | -479.7% | +139.1 |
| Q2 FY2021 | Jun 30, 2021 | -412.7% | +121.0 |
| Q1 FY2021 | Mar 31, 2021 | -721.1% | +34.4 |
| Q4 FY2020 | Dec 31, 2020 | -655.9% | −208.9 |
| Q3 FY2020 | Sep 30, 2020 | -618.8% | −191.2 |
| Q2 FY2020 | Jun 30, 2020 | -533.7% | +224.0 |
| Q1 FY2020 | Mar 31, 2020 | -755.5% | −149.0 |
| Q4 FY2019 | Dec 31, 2019 | -447.0% | −190.0 |
| Q3 FY2019 | Sep 30, 2019 | -427.6% | +249.8 |
| Q2 FY2019 | Jun 30, 2019 | -757.7% | +368.4 |
| Q1 FY2019 | Mar 31, 2019 | -606.5% | +603.2 |
| Q4 FY2018 | Dec 31, 2018 | -257.0% | – |
| Q3 FY2018 | Sep 30, 2018 | -677.3% | – |
| Q2 FY2018 | Jun 30, 2018 | -1126.1% | – |
| Q1 FY2018 | Mar 31, 2018 | -1209.7% | – |
See a number that looks wrong?